EHF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.082000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.368400E-01
Normal-vs-Stage2
3.537600E-01
Normal-vs-Stage3
9.038000E-01
Normal-vs-Stage4
4.759000E-01
Stage1-vs-Stage2
5.434600E-01
Stage1-vs-Stage3
2.576400E-01
Stage1-vs-Stage4
6.263600E-01
Stage2-vs-Stage3
2.226000E-01
Stage2-vs-Stage4
9.910600E-01
Stage3-vs-Stage4
2.764000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.120000E-01
Normal-vs-AfricanAmerican
4.495400E-01
Normal-vs-Asian
5.944200E-01
Caucasian-vs-AfricanAmerican
9.537400E-01
Caucasian-vs-Asian
4.142800E-01
AfricanAmerican-vs-Asian
4.445400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.562600E-01
Normal-vs-Female
4.918800E-01
Male-vs-Female
5.158400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.994400E-01
Normal-vs-Age(41-60Yrs)
2.865200E-01
Normal-vs-Age(61-80Yrs)
4.476600E-01
Normal-vs-Age(81-100Yrs)
6.285600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.420200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.716400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.858800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.780090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.032800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.049200E-01
Normal-vs-Daily Drinker
5.719000E-01
Normal-vs-Weekly Drinker
8.469800E-01
Normal-vs-Occasional Drinker
2.219600E-01
Normal-vs-Social Drinker
3.339400E-01
Non Drinker-vs-Daily Drinker
5.842800E-01
Non Drinker-vs-Weekly Drinker
2.445400E-01
Non Drinker-vs-Occasional Drinker
1.031550E-01
Non Drinker-vs-Social Drinker
7.535200E-01
Daily Drinker-vs-Weekly Drinker
5.108000E-01
Daily Drinker-vs-Occasional Drinker
5.600200E-02
Daily Drinker-vs-Social Drinker
4.446600E-01
Weekly Drinker-vs-Occasional Drinker
3.331800E-02
Weekly Drinker-vs-Social Drinker
1.959980E-01
Occasional Drinker-vs-Social Drinker
2.023400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.60729999981935E-07
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.62447832963153E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.773200E-01
Grade 1-vs-Grade 3
1.011220E-01
Grade 1-vs-Grade 4
3.60729999981935E-07
Grade 2-vs-Grade 3
4.868400E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.62447832963153E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.275800E-01
Normal-vs-NonDiabetic
4.375600E-01
Diabetic-vs-NonDiabetic
5.933600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.899200E-01
Normal-vs-NoPancreatitis
4.772600E-01
Pancreatitis-vs-NoPancreatitis
9.558400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.122200E-01
Normal-vs-N1
3.402600E-01
N0-vs-N1
8.253800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.386160E-01
Normal-vs-TP53-NonMutant
3.289600E-01
TP53-Mutant-vs-TP53-NonMutant
6.269200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
